Investment Fund Presses Hologic to Further Increase Shareholder Value | GenomeWeb

NEW YORK (GenomeWeb News) – An activist investment fund disclosed a 7.3 percent stake in Hologic and called for continued disclosure of the company's plans to pay down its debt and return cash to its shareholders.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: epigenetic contributors to type 1 diabetes, assembly algorithm to detect structural variations, and more.

The Financial Times looks into how sequencing is moving into the clinic.

Mitochondrial replacement therapy may soon be occurring in the UK, according to the Guardian.

The US House of Representatives has passed the latest version of the 21st Century Cures Act.